An Exploratory Study Examining Biopsychosocial Markers of Anxiety and Depression

Part of paid clinical trials in New York, New York.

Sponsor
Singula Institute
Study ID
NCT05466851
Status
Recruiting
Apply to this trial

Conditions

  • Anxiety Disorders
  • Depression
  • Stress Related Disorder

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Not accepted

Study Details

This research study is studying how thoughts, feelings, surroundings, and individual biology may contribute to why and how people experience anxiety or depression. We are trying to find out the wide variety of reasons that people may experience anxiety or depression, and why different people are helped by different forms of treatment. We are trying to determine why people stay in treatment, and what factors contribute to a positive or negative response to treatment. These reasons may be due to thoughts, feelings, beliefs, personality, biology, social support network, life events, and barriers to treatment. A wide range of information about factors that impact anxiety and depression will be included. These include, among others, measures of inflammation, hormone levels, behavior, spoken language, personality, medical history, social determinants of health, and attitudes toward mental health and its treatment. The study involves psychological and psychiatric treatments in the form of psychotherapy and medication management. The participant will be asked to set specific goals for study treatment, and to provide videos between sessions about relevant medication, emotional, and sleep factors in their life. In summary, this study will collect biological, psychological, and social factors that may play a role in anxiety and depression. This will inform both individual's diagnosis and treatment and will be used in a later set of analyses that can inform diagnosis and treatment for other individuals who share similar characteristics.

Key Dates

Start date
Mar 1, 2023
Status verified
Apr 2024
Primary completion
Mar 31, 2032
Completion
Mar 31, 2032

Study Design

Enrollment
200 participants (estimated)

Primary Outcome Measure

Treatment Engagement and Adherence [ Time Frame: Through Phase 1 completion, an average of 2-4 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Singula Institute, 353 Lexington Avenue (Room 600)New YorkNew York10016
Jen Tung, RN, MA
[email protected]
212-531-5826
Marc S Lener, MD
[email protected]
(240) 389-2381

Find similar trials in New York, NY

By condition
Depression
By specialty
PsychiatryMental healthBehavioral health
By research site
Singula Institute, 353 Lexington Avenue (Room 600)· New York, NY

Related Studies